Relationship between BrainAge Polygenetic Risk Score and plasma biomarkers in the A4/LEARN studies
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background and Objectives
To examine the association between genetic predisposition to accelerated brain aging—measured with polygenic risk scores (PRS) derived from BrainAge models—and plasma biomarkers of Alzheimer’s disease (AD), with attention to age and sex-specific effects.
Methods
We analyzed 1994 cognitively unimpaired participants from the A4/LEARN studies (71.5±4.8 years; 41% male). We computed the genetic risk of accelerated grey matter loss associated with age using GWAS data from previous studies. Baseline plasma biomarkers included pTau 217 (N=980; Eli Lilly immunoassay), and GFAP and NfL (N=1636; Roche Elecsys immunoassay). General linear models tested associations between each PRS and each biomarker, including PRS-by-age interaction terms. Analyses were additionally stratified by sex.
Results
BrainAge PRS moderated the association between age and pTau 217 levels (β=0.08±0.03, p=0.0086), such that higher PRS for BrainAge was associated with increased pTau 217 at older ages. Results were robust to covariates. This association was significant in females but not in males. No significant associations were found with GFAP or NfL.
Discussion
Genetic risk for accelerated grey matter loss with aging is associated with elevated pTau 217 levels in cognitively unimpaired older females. These findings suggest a sex- and age-specific genetic link between brain aging and early AD pathology.
